Amanda E. Rutten

Amanda E. Rutten serves as a key procurement professional within the Naval Medical Logistics Command, supporting the Department of Defense’s mission to sustain combat-ready medical forces through the acquisition of advanced diagnostic and laboratory instrumentation. She manages the full lifecycle of high-priority contracts for analytical laboratory instruments critical to point-of-care diagnostics, battlefield medical analysis, and preventive health surveillance. Her acquisitions directly enable the Navy and Marine Corps to maintain operational medical superiority in austere and global environments, ensuring timely delivery of precision testing equipment that supports clinical decision-making under mission-critical conditions. Rutten collaborates with a network of specialized manufacturers and engineering firms that produce FDA-cleared, military-spec analytical instruments, including mass spectrometers, blood gas analyzers, and automated clinical chemistry systems. While specific contractor names are not publicly disclosed, her procurement pattern reflects consistent engagement with Tier-1 medical technology vendors possessing robust defense supply chain credentials and ISO 13485 certification. Her working relationships emphasize technical compliance, rapid sustainment support, and ruggedized product configurations tailored to expeditionary medical operations. Rutten’s contracting activity is exclusively non-set-aside, with 100% of procurements conducted under full and open competition. This reflects a strategic prioritization of technical performance, interoperability, and mission-critical reliability over socioeconomic preferences, aligning with the command’s urgent operational tempo and stringent equipment standards. While small business participation is not formally targeted, vendors must still meet rigorous qualification thresholds to ensure seamless integration into the Navy’s medical logistics infrastructure. Her primary focus lies within NAICS 334516, Analytical Laboratory Instrument Manufacturing, where she procures precision diagnostic systems used in hematology, microbiology, and biochemistry analysis. Her expertise spans the acquisition of complex, FDA-regulated medical devices requiring extensive technical evaluation, environmental testing, and lifecycle support—ensuring that every instrument deployed meets the exacting demands of naval medical operations.